• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Svelte Medical Systems Inc.

Svelte Medical launches pivotal trial for drug-eluting stent-on-a-wire

January 11, 2018 By Sarah Faulkner

The first patient has been enrolled in Svelte Medical System‘s Optimize pivotal trial, which is designed to evaluate the safety and efficacy of Svelte’s drug-eluting stent integrated delivery system and rapid exchange platforms. The 2,000-person trial comes in the wake of a first-in-man trial for Svelte’s product and a study comparing the system with Medtronic‘s (NYSE:MDT) Resolute […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pharmaceutical, Vascular Tagged With: Medtronic, Svelte Medical Systems Inc.

Svelte Medical wins CE Mark for Direct coronary stent

October 24, 2016 By Sarah Faulkner

Svelte Medical Systems said today that it received CE Mark approval in the European Union for its Direct sirolimus-eluting coronary stent. The stent uses a coating of sirolimus and a natural, amino acid-based polyesteramide bioresorbable drug carrier. Direct stenting minimizes the use of pre-dilation balloons, lessening the cost and time of stent procedures. Direct Rx is specifically […]

Filed Under: Cardiovascular, Drug-Eluting Stents, Regulatory/Compliance Tagged With: Svelte Medical Systems Inc.

Svelte Medical launches Slender IDS in Europe

January 19, 2016 By Fink Densford

Svelte Medical Systems said today it initiated a select launch of its Slender sirolimus-eluting coronary stent-on-a-wire integrated delivery system in Europe. The device incorporates Japan’s Asahi Intecc (TYO:7747) guide wire technology, specialized balloon design and a bioresorbable drug carrier from DSM Biomedical. The Slender’s all-in-one’ fixed-wire system with combined technologies allows for “precise steering” and controlled balloon […]

Filed Under: Business/Financial News, Catheters Tagged With: Svelte Medical Systems Inc.

Svelte Medical granted CE Mark for Slender IDS drug-eluting stent catheter

December 15, 2015 By Fink Densford

Svelte Medical Systems said today it won CE Mark approval in the European Union for its Slender sirolimus-eluting coronary stent-on-a-wire integrated delivery system designed to treat coronary artery disease. The Slender IDS is the lowest-profile drug-eluting stent on the market, according to the New Providence, N.J.-based company. Approval in the EU came based on data […]

Filed Under: 510(k), Cardiac Implants, Cardiovascular, Catheters, Drug-Eluting Stents, Regulatory/Compliance, Stents Tagged With: Svelte Medical Systems Inc.

MDT gets in on $17m Series B for Glooko | Medtech funding for the week of March 16, 2015

March 20, 2015 By MassDevice Leave a Comment

Diabetes: Medtronic gets in on $17m Series B for Glooko

March 17, 2015 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Canaan Partners, Glooko, Indiegogo, Pegasus Therapeutics, Svelte Medical Systems Inc.

Svelte Medical adds $16m for wrist-delivered stent

March 19, 2015 By Brad Perriello Leave a Comment

Svelte Medical raises another $16m

Svelte Medical Systems today said it plans to use the $16 million it just raised to commercialize its wrist-delivered stenting technology.

New Providence, N.J.-based Svelte said the round involved current investors and was led by CNF Investments, the West Health Investment Fund and New Science Ventures.

Filed Under: Drug-Eluting Stents, Funding Roundup, News Well Tagged With: Svelte Medical Systems Inc., Venture Capital/Private Equity

Medtech funding for the week of Mar. 10, 2014

March 14, 2014 By MassDevice staff Leave a Comment


Funding: Domain Surgical raises $11.6M for cutting tool

March 10, 2014 by Arezu Sarvestani

Funding: Domain Surgical raises $11.6M for cutting tool

Filed Under: Funding Roundup, News Well Tagged With: Brainsway, Domain Surgical, Svelte Medical Systems Inc.

Svelte Medical raises another $5M

March 12, 2014 By Arezu Sarvestani Leave a Comment

Svelte Medical raises another $5M

New Jersey-based Svelte Medical plans to accelerate regulatory efforts for its interventional cardiology products thanks to a new $5 million investment from West Health Investment Fund.

Filed Under: Drug-Eluting Stents, Funding Roundup, News Well, Stents Tagged With: Svelte Medical Systems Inc.

Svelte Medical Systems raises $22 million

October 31, 2013 By Chris Walker Leave a Comment

Svelte Medical Systems raises $22M from New Science Ventures, others

Svelte Medical Systems said it raised $22 million to complete a clinical trial of its coronary stent platforms, taking its total raise to $65 million since 2007.

Venture capital shops New Science Ventures and CNF Investments led the latest round for New Providence, N.J.-based Svelte, which the medical device company said it plans to use to complete its Direct II clinical trial as it gears up for commercialization.

Filed Under: Funding Roundup, News Well, Stents Tagged With: Clinical Trials, CNF Investments, New Science Ventures, Svelte Medical Systems Inc., Venture Capital/Private Equity

Svelte Medical launches drug-eluting stent trial

January 30, 2013 By MassDevice staff

Svelte Medical

Svelte Medical said it launched the Direct II Phase II clinical trial of its drug-eluting stent comparing the device with Medtronic‘s (NYSE:MDT) Resolute DES.

The Svelte device elutes the anti-stenosis drug sirolimus using a bioabsorbable carrier made of amino acids, unlike the polymer-based drug carrier used in the Resolute stent.

Filed Under: Drug-Eluting Stents, News Well Tagged With: Clinical Trials, Stent Wars, Svelte Medical Systems Inc.

Svelte treats 1st patient with Svelte Acrobat stent system

December 26, 2012 By MassDevice staff Leave a Comment

Svelte Medical Systems logo

Svelte Medical Systems treated the 1st patient in its clinical study, evaluating the company’s Svelte Acrobat Integrated Delivery System in comparison with conventional coronary stent devices in treatment of patients with lesions eligible for direct stenting.

The Svelte coronary stent IDS is low profile and highly flexible, designed to streamline stenting and thereby reduce procedure time and cost, the company said.

Filed Under: News Well, Stents Tagged With: Clinical Trials, Svelte Medical Systems Inc.

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS